Boston Scientific Corp (BSX)
67.34
-0.08
(-0.12%)
USD |
NYSE |
Apr 19, 16:00
67.24
-0.10
(-0.15%)
After-Hours: 19:36
Boston Scientific Cash from Operations (Quarterly): 957.00M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 957.00M |
September 30, 2023 | 698.00M |
June 30, 2023 | 658.00M |
March 31, 2023 | 190.00M |
December 31, 2022 | 807.00M |
September 30, 2022 | 470.00M |
June 30, 2022 | 307.00M |
March 31, 2022 | -58.00M |
December 31, 2021 | 478.00M |
September 30, 2021 | 465.00M |
June 30, 2021 | 643.00M |
March 31, 2021 | 284.00M |
December 31, 2020 | 673.00M |
September 30, 2020 | 643.00M |
June 30, 2020 | 269.00M |
March 31, 2020 | -77.00M |
December 31, 2019 | 692.00M |
September 30, 2019 | 502.00M |
June 30, 2019 | 292.00M |
March 31, 2019 | 350.00M |
December 31, 2018 | 19.00M |
September 30, 2018 | 501.00M |
June 30, 2018 | -403.00M |
March 31, 2018 | 193.00M |
December 31, 2017 | 684.00M |
Date | Value |
---|---|
September 30, 2017 | 452.00M |
June 30, 2017 | 297.00M |
March 31, 2017 | -7.00M |
December 31, 2016 | 676.00M |
September 30, 2016 | -31.00M |
June 30, 2016 | 421.00M |
March 31, 2016 | 116.00M |
December 31, 2015 | 420.00M |
September 30, 2015 | 408.00M |
June 30, 2015 | 60.00M |
March 31, 2015 | -197.00M |
December 31, 2014 | 440.00M |
September 30, 2014 | 346.00M |
June 30, 2014 | 285.00M |
March 31, 2014 | 198.00M |
December 31, 2013 | 275.00M |
September 30, 2013 | 251.00M |
June 30, 2013 | 397.00M |
March 31, 2013 | 187.00M |
December 31, 2012 | 389.00M |
September 30, 2012 | 272.00M |
June 30, 2012 | 407.00M |
March 31, 2012 | 212.00M |
December 31, 2011 | 349.00M |
September 30, 2011 | 366.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-77.00M
Minimum
Mar 2020
957.00M
Maximum
Dec 2023
468.05M
Average
478.00M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
Stryker Corp | 1.528B |
Abbott Laboratories | 3.038B |
Axonics Inc | 5.63M |
Edwards Lifesciences Corp | 136.60M |
Intuitive Surgical Inc | 228.30M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -1.053B |
Cash from Financing (Quarterly) | 15.00M |
Free Cash Flow | 1.703B |
Free Cash Flow Per Share (Quarterly) | 0.4673 |
Free Cash Flow to Equity (Quarterly) | 488.00M |
Free Cash Flow to Firm (Quarterly) | 732.91M |
Free Cash Flow Yield | 1.73% |